Hierarchical order of distinct autoantibody spreading and progression to type 1 diabetes in the TEDDY Study
Author:
Vehik Kendra,Bonifacio Ezio,Lernmark Ake,Yu Liping,Williams Alistair,Schatz Desmond,Rewers Marian,She Jin-Xiong,Toppari Jorma,Hagopian William,Akolkar Beena,Ziegler Anette G.,Krischer Jeffrey P.,Group the TEDDY Study
Abstract
<b>Objective:</b>
The first-appearing β-cell
autoantibody has been shown to influence risk of type 1 diabetes. Here, we
assessed risk of autoantibody spreading to the second-appearing autoantibody
and further progression to clinical disease in the Environmental Determinants
of Diabetes in the Young study.
<p><b>Research Design and
Methods:</b> Eligible children with increased HLA-DR-DQ genetic
risk for type 1 diabetes were followed quarterly from age 3 months up to 15
years for development of a single first-appearing autoantibody (GADA, IAA or
IA-2A) and subsequent development of a single second-appearing autoantibody and
progression to type 1 diabetes. Autoantibody positivity was defined as
positivity for a specific autoantibody at two consecutive visits confirmed in
two laboratories. ZnT8A was measured in
children who developed another autoantibody.</p>
<p><b>Results:</b>
There were 608 children who developed a single first-appearing autoantibody (IAA,
n=282 or GADA, n=326) with a median follow-up of 12.5 years from birth. The
risk of a second-appearing autoantibody was independent of GADA versus IAA as a
first-appearing autoantibody (adjusted-HR=1.12, 95%CI=0.88-1.42, <i>P</i>=0.36). Second-appearing GADA, IAA, IA-2A or
ZnT8A conferred an increased risk of type 1 diabetes compared to children who remained single autoantibody
positive (IAA- or GADA-second: adjusted-HR=6.44 95%CI=3.78-10.98; IA-2A-second:
adjusted-HR=16.33 95%CI=9.10-29.29,<i> P</i><0.0001;
ZnT8A-second: adjusted-HR=5.35 95%CI=2.61-10.95, <i>P</i><0.0001). In children
who developed a distinct second autoantibody, IA-2A (adjusted-HR=3.08
95%CI=2.04-4.65, <i>P</i><0.0001)
conferred a greater risk of progression to type 1 diabetes as compared to GADA
or IAA. Additionally, both a younger initial age at seroconversion and shorter
time to the development of the second-appearing autoantibody increased the risk
for type 1 diabetes.</p>
<p><b>Conclusions:</b>
The hierarchical order of distinct autoantibody spreading was independent of
the first-appearing autoantibody type, age-dependent and augmented the risk of
progression to type 1 diabetes.<br>
</p>
Publisher
American Diabetes Association
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献